Your session is about to expire
← Back to Search
Resilience-Based Intervention for HIV/AIDS Stigma
Study Summary
This trial will test a resilience-based intervention to reduce HIV-related stigma in Guangxi, China. The primary outcome is viral suppression among people living with HIV (PLWH), and the intermediate outcomes include resilience resources at the levels of individuals, the PLWH's real or surrogate family members, and healthcare facilities, as well as chronic stress response and adherence to treatment and care.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not in jail, planning to move, or in another study, and can participate fully.I am over 18, support someone with HIV, referred by them, and open to study participation.I am over 18, work at a participating HIV clinic, and regularly see HIV patients.
- Group 1: Family member intervention
- Group 2: Health care provider intervention
- Group 3: PLWH intervention sessions
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available vacancies in this clinical experiment?
"According to clinicaltrials.gov, this medical study is not presently recruiting patients. It was initiated on December 1st 2021 and the latest update was posted on December 13th 2021. Nonetheless, there are 534 other trials actively looking for volunteers right now."
What are the major aims of this investigation?
"Over the course of 36 months, 7 evaluations will take place to measure if there has been a change in CD4 counts among those living with HIV. Secondary outcomes include self-reported depressive symptoms scored from 0 to 60 and changes in HIV disclosure patterns as well as mental health status like depression or burnout amongst healthcare professionals."
Share this study with friends
Copy Link
Messenger